ConductScience.org, home

Comparison · NCT03284398-ad905415

Three-Chambered Bag vs Hospital-compounded Bag: Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Three-Chambered Bag vs Hospital-compounded Bag: Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB). Trial comparisons, record NCT03284398-ad905415. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03284398-ad905415

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.04610.03890.0546wilson
Risk in group 20.1090.09120.13wilson
Risk difference, group 1 minus group 2-0.0631-0.0855-0.0431newcombe hybrid score
Risk ratio, group 1 over group 20.4220.330.541log
Odds ratio, group 1 over group 20.3940.3010.516log
Number needed to treat, for one fewer participant with the outcome on Three-Chambered Bag than on Hospital-compounded Bag15.811.723.2from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Three-Chambered BagTreatment with industrially-compounded PN formulation in three-chambered bag1272,753OG000
Group 2Hospital-compounded BagTreatment with Hospital-compounded PN bag106970OG001

Outcome

Type
PRIMARY
Title
Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB)
Description
Confirmation of BSI required fulfillment of all of the following criteria:~* International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code for sepsis (038.x), septicemia (995.91), severe sepsis (995.92), septic shock (785.52), bacteremia (790.7), unspecified infection due to central venous catheter (999.31), or BSI due to central venous catheter (999.32)~* Positive blood culture collected during PN administration~* Concomitant antimicrobial therapy
Time frame
Entire study period, from January 1, 2013 and December 31, 2015
Population

Source ClinicalTrials.gov

Trial

Title
Three-Chamber Bags Retrospective Study in Spain
NCT number
NCT03284398
Phases
Conditions
Parenteral Nutrition, Blood Stream Infection
Interventions
Lead sponsor
Fresenius Kabi
Results first posted
2021-01-08

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03284398-ad905415